<DOC>
	<DOCNO>NCT02262000</DOCNO>
	<brief_summary>This study help researcher learn best dose radiation use treat large early stage non-small cell lung cancer ( NSCLC ) treatment call stereotactic ablative radiotherapy ( SABR ) . Current treatment SABR early stage NSCLC show positive response . But , large early stage NSCLC may better give different SABR dos use routine early stage NSCLC treatment . It understand dose best treat large early stage NSCLC . Therefore , study help researcher learn give high dose use SABR period 5-10 treatment day increase chance cure large early stage NSCLC .</brief_summary>
	<brief_title>Phase II Image Guided Stereotactic Ablative Radiotherapy Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>Treatment Plan : 7.5 Gy x 10 daily fraction deliver VMAT regular IMRT . - Optional schedule 12 Gy x 5 daily fraction may also use ONLY situation dose constraint organ risk EASILY meet optimal PTV coverage achieve ; 7.5 Gy x 10 daily fraction schedule prefer . - All dos prescribe tumor periphery . For protocol , patient follow 2 year post radiation therapy .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>NonSmall Cell Lung Cancer T2N0M0 T3 ( PL3 ) N0M0 Locally recurrent â‰¤ 7 cm Surgically inoperable ECOG Performance 02 Pacemaker side tumor Pregnant Infection require IV antibiotic Concomitant adjuvant antineoplastic chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Non Small Cell Lung Cancer</keyword>
	<keyword>Surgically inoperable</keyword>
	<keyword>Radiation Therapy</keyword>
</DOC>